Comparative efficacy should have a "formal role in drug licensing"
08 September 2011
Alex Shimmings
Please Login to read the full article.
08 September 2011
Alex Shimmings
Please Login to read the full article.
RELATED CONTENT
NEWS
- NICE to review Fabre's Javlor again as comparison with unlicensed drugs deemed unfair
- US Capitol Capsule: Senate & Supreme Court tackle issues of US patent system
- Big pharma abandoning HIV discounts in middle-income countries, MSF claims
- Price cut hobbles Japan's prescription market in 2010
COMMENT
FEATURES
Other Informa Features
